Free Trial

Cardiff Oncology (CRDF) SEC Filings & 10K Form

Cardiff Oncology logo
$3.74 -0.08 (-2.09%)
Closing price 04:00 PM Eastern
Extended Trading
$3.74 -0.01 (-0.13%)
As of 04:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cardiff Oncology SEC Filings

DateFilerForm TypeView
02/27/2025
3:11 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/27/2025
3:15 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:00 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
1:48 PM
Cardiff Oncology, Inc. (Subject)
Cardiff Oncology (Subject)
PFIZER INC (Filed by)
Form SCHEDULE 13G/A
12/18/2024
3:37 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Levine James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:06 PM
Cardiff Oncology, Inc. (Subject)
Cardiff Oncology (Subject)
COMMODORE CAPITAL LP (Filed by)
Form SCHEDULE 13G
12/16/2024
4:00 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:15 AM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 424B5
12/10/2024
5:02 AM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Cardiff Oncology, Inc. (Subject)
Cardiff Oncology (Subject)
Form SC 13G
06/17/2024
5:10 AM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form DEFA14A
06/03/2024
3:06 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form DEFA14A
03/07/2024
5:39 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Erlander Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:39 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Smeal Tod (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:40 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Kabbinavar Fairooz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:40 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Levine James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRDF) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners